enkephalin, leucine has been researched along with Liver Dysfunction in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Losowsky, MS; Thornton, JR | 1 |
| Babkina, NV; Karelin, AA; Korotkina, RN; Kuzin, MI; Shloznikov, BM | 1 |
2 other study(ies) available for enkephalin, leucine and Liver Dysfunction
| Article | Year |
|---|---|
Plasma leucine enkephalin is increased in liver disease.
Topics: Acute Disease; Adolescent; Adult; Aged; Enkephalin, Leucine; Female; Humans; Liver Cirrhosis; Liver Diseases; Male; Middle Aged | 1989 |
[Experimental study of the hepatoprotective effect of transcranial transcutaneous electrostimulation and the synthetic analog of leu-enkephalin dalargin].
Topics: Animals; Brain; Electric Stimulation Therapy; Electronarcosis; Endorphins; Enkephalin, Leucine; Enkephalin, Leucine-2-Alanine; Histidine Ammonia-Lyase; Liver; Liver Diseases; Male; Rats; Transcutaneous Electric Nerve Stimulation; Urokinase-Type Plasminogen Activator | 1988 |